GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of IMM.L
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Immupharma Plc stock upgraded from Hold/Accumulate to Buy Candidate after Thursday trading session.
(Updated on Apr 18, 2024)

Buy or Hold candidate since Mar 11, 2024 Gain 50.84% PDF

The Immupharma Plc stock price fell by -2.40% on the last day (Thursday, 18th Apr 2024) from £2.30 to £2.24. During the last trading day the stock fluctuated 7.79% from a day low at £2.20 to a day high of £2.37. The price has risen in 7 of the last 10 days but is still down by -3.24% for this period. Volume has increased on the last day by 129 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 735 thousand shares were bought and sold for approximately £1.65 million.

The stock lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 77.03% during the next 3 months and, with a 90% probability hold a price between £2.59 and £4.97 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

IMM.L Signals & Forecast

A sell signal was issued from a pivot top point on Tuesday, April 02, 2024, and so far it has fallen -12.84%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely. Some positive signals were issued as well, and these may have some influence on the near short-term development. The Immupharma Plc stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately £2.37. On a fall, the stock will find some support from the long-term average at approximately £1.92. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal.

Support, Risk & Stop-loss for Immupharma Plc stock

On the downside, the stock finds support just below today's level from accumulated volume at £2.00 and £1.92. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Immupharma Plc finds support just below today's level at £2.00. If this is broken, then the next support from accumulated volume will be at £1.92 and £1.86.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved £0.171 between high and low, or 7.79%. For the last week, the stock has had daily average volatility of 10.02%.

Our recommended stop-loss: £2.12 (-5.34%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 12 days ago.)

Trading Expectations (IMM.L) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect Immupharma Plc to open at £2.27, and during the day (based on 14 day Average True Range), to move between £1.94 and £2.54, which gives a possible trading interval of +/-£0.296 (+/-13.21%) up or down from last closing price. If Immupharma Plc takes out the full calculated possible swing range there will be an estimated 26.42% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at £2.45 (9.38%) than the support at £2.00 (10.94%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Immupharma Plc stock A Buy?

Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

Current score: 1.420 Buy Candidate Upgraded

Predicted Opening Price for Immupharma Plc of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
£2.27 ( 1.36%) £2.24

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for IMM.L

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.44 9.01 %
R2 2.38 6.09 %
R1 2.34 4.28 %
Current price: 2.24
Support S1 2.21 -1.56 %
S2 2.16 -3.36 %
S3 2.10 -6.29 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.57 14.73 %
R2 2.48 10.49 %
R1 2.45 9.38 %
Current price 2.24
Support S1 2.00 -10.94%
S2 1.92 -14.51%
S3 1.86 -17.19%

IMM Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Dec 14, 2021 Dec 14, 2021 Dec 14, 2021 £300.00 5,357.14%

FAQ

What is the symbol for Immupharma Plc Stock and on which exchange is it traded?
The symbol for Immupharma Plc is IMM.L and it is traded on the XLON (London Stock Exchange).

Should I buy or sell Immupharma Plc Stock?
Several of the signals/indicators are negative, and we believe that this will affect on the development for the next days and maybe possible weeks. However, over time, we think that today's level holds a possible buying opportunity and that the price will be higher during or at the end of this 3-month period. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Buy candidate.

How to buy Immupharma Plc Stock?
Immupharma Plc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Immupharma Plc Stock.

What's the current price of Immupharma Plc Stock?
As of the end of day on the 2024-04-18, the price of an Immupharma Plc (IMM.L) share was £2.24.

What is the 52-week high and low for Immupharma Plc Stock?
The 52-week high for Immupharma Plc Stock is £3.80 and the 52-week low is £0.82.

What is the market capitalization of Immupharma Plc Stock?
As of the 2024-04-18, the market capitalization of Immupharma Plc is 9.328M.

When is the next earnings date for Immupharma Plc?
The upcoming earnings date for Immupharma Plc is May 09, 2024.
Click to get the best stock tips daily for free!

About Immupharma Plc

Immupharma Plc ImmuPharma plc, a biopharmaceutical company, discovers and develops peptide-based therapeutics. Its peptide-based therapeutics are used in the therapy areas of autoimmunity and inflammation, and anti-infectives. The company's lead product candidate is the Lupuzor, an autophagy immunomodulator, which is in Phase III clinical trial for the treatment of lupus, an autoimmune chronic inflammatory disease. Its other product candidates include BioAMB, a... IMM.L Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT